HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Kwality Pharmaceuticals secures EU-GMP approval from Hungary for Cephalosporin, Oncology facilities
Nov-04-2026

Kwality Pharmaceuticals has further strengthened its regulatory credentials with EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities, complementing its earlier EU-GMP approval from Bulgaria. This milestone significantly expands the company’s EU-GMP-approved manufacturing capabilities across specialised pharmaceutical segments, strengthening its competitive positioning in highly regulated markets. 

It is expected to create substantial business opportunities by attracting new licensing opportunities, accelerate product registrations and improve its competitiveness in high-value global markets. This achievement marks another important step towards expanding the company’s international footprint and driving sustainable business growth.  

Kwality Pharmaceuticals is a pharmaceutical formation company. It is engaged in manufacturing finished pharmaceutical formulations in dosage form.

  RELATED NEWS >>